Reid Waldman, Veradermics CEO (Tim Tadder/The Forbes Collection via Contour RA by Getty Images) July 15, 2026 07:04 AM EDT R&D Veradermics declares first efficacy win in women for hair loss drug Ayisha Sharma News Reporter Veradermics is for the first time reporting positive efficacy of its oral formulation of minoxidil in female pattern hair loss, which broadens the market potential … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
endpoints· 6d ago
saveVeradermics declares first efficacy win in women for hair loss drug
July 15, 2026read original ↗
Veradermics is for the first time reporting positive efficacy of its oral formulation of minoxidil in female pattern hair loss, which broadens the market potential of its flagship asset.
96 words · extracted 6d agoread original ↗
🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that